Journal of Toxicological Sciences 2009-04-01

Identification of an N-acetylcysteine conjugate in the urine after oral administration of 2,4-dichloro-1-nitrobenzene to rats.

Makoto Ohnishi, Makoto Take, Seigo Yamamoto, Shoji Fukushima, Hirofumi Yajima

Index: J. Toxicol. Sci. 34(2) , 233-7, (2009)

Full Text: HTML

Abstract

Oral administration of 2,4-dichloro-1-nitrobenzene (2,4-DCNB) causes kidney tumors in the rat. The objective of the present study was to identify the chemical structure of 2,4-DCNB metabolites in urine. Urine from 2,4-DCNB fed rats was more yellow than urine from control rats, exhibiting a broad UV-spectrum around a peak wavelength of 360 nm; the control urine did not have an absorbance. The yellow component was extracted and analyzed. The optical properties of the yellow component were the same as the N-acetylcysteine conjugate of 1,4-dichloro-2-nitrobenzene (1,4-DCNB): 1,4-DCNB is secreted in urine as an N-acetylcysteine conjugate. LC-MS/MS analyses of this yellow component demonstrated its chemical structure to be the N-acetylcysteine conjugate of 2,4-DCNB. Nuclear overhauser effect and LC-MS/MS analyses revealed the structural isomer of this 2,4-DCNB metabolite as N-acetyl-S-(5-chloro-2-nitrophenyl)-L-cysteine. We also discuss the possibility that the N-acetylcysteine conjugate identified in this study plays a role as a proximate carcinogen in the formation of kidney tumors.


Related Compounds

Related Articles:

Control of the immune response to contact sensitizing chemicals by cutaneous antigen-presenting cells.

1987-07-01

[Br. J. Dermatol. 117(1) , 1-9, (1987)]

Contribution of caffeine and flavanols in the induction of hepatic Phase II activities by green tea.

1998-08-01

[Food Chem. Toxicol. 36(8) , 617-21, (1998)]

Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat.

2000-06-30

[Cancer Lett. 154(2) , 201-10, (2000)]

Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants.

1988-03-01

[Arch. Dermatol. 124(3) , 396-8, (1988)]

Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein.

2007-06-01

[Toxicol. In Vitro 21(4) , 723-33, (2007)]

More Articles...